Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.

In order to assess the potential of interleukin 7 (IL-7) as an immunotherapeutic agent in human melanoma, we have evaluated the in vitro activity of IL-7-induced lymphokine-activated killer (LAK) cells from patients with advanced melanoma against allogeneic and autologous melanoma cells. Peripheral...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Böhm, M., Möller, P., Kalbfleisch, U., Worm, M., Czarnetzki, B. M., Schadendorf, D.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1994
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033302/
https://ncbi.nlm.nih.gov/pubmed/8018541
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires